154 related articles for article (PubMed ID: 24465655)
1. A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study.
Pereira NL; Redfield MM; Scott C; Tosakulwong N; Olson TM; Bailey KR; Rodeheffer RJ; Burnett JC
PLoS One; 2014; 9(1):e85708. PubMed ID: 24465655
[TBL] [Abstract][Full Text] [Related]
2. Association of NPR3 polymorphism with risk of essential hypertension in a Chinese population.
Kuang DB; Zhou JP; Li MP; Tang J; Chen XP
J Clin Pharm Ther; 2017 Oct; 42(5):554-560. PubMed ID: 28497617
[TBL] [Abstract][Full Text] [Related]
3. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
[TBL] [Abstract][Full Text] [Related]
5. Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes.
Saulnier PJ; Roussel R; Halimi JM; Lebrec J; Dardari D; Maimaitiming S; Guilloteau G; Prugnard X; Marechaud R; Ragot S; Marre M; Hadjadj S;
Diabetes Care; 2011 May; 34(5):1199-204. PubMed ID: 21464461
[TBL] [Abstract][Full Text] [Related]
6. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P
J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975
[TBL] [Abstract][Full Text] [Related]
7. Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.
Uraizee I; Cheng S; Hung CL; Verma A; Thomas JD; Zile MR; Aurigemma GP; Solomon SD
Am J Hypertens; 2013 Oct; 26(10):1234-41. PubMed ID: 23792241
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
9. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
[TBL] [Abstract][Full Text] [Related]
10. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.
Abhayaratna WP; Marwick TH; Becker NG; Jeffery IM; McGill DA; Smith WT
Am Heart J; 2006 Nov; 152(5):941-8. PubMed ID: 17070165
[TBL] [Abstract][Full Text] [Related]
11. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of left ventricular diastolic dysfunction in a general population.
Kuznetsova T; Herbots L; López B; Jin Y; Richart T; Thijs L; González A; Herregods MC; Fagard RH; Díez J; Staessen JA
Circ Heart Fail; 2009 Mar; 2(2):105-12. PubMed ID: 19808325
[TBL] [Abstract][Full Text] [Related]
13. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
[TBL] [Abstract][Full Text] [Related]
15. High frequency of diastolic dysfunction in a population-based cohort of elderly women--but poor association with the symptom dyspnea.
Germing A; Gotzmann M; Schikowski T; Vierkötter A; Ranft U; Krämer U; Mügge A
BMC Geriatr; 2011 Nov; 11():71. PubMed ID: 22047619
[TBL] [Abstract][Full Text] [Related]
16. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.
Cannone V; Boerrigter G; Cataliotti A; Costello-Boerrigter LC; Olson TM; McKie PM; Heublein DM; Lahr BD; Bailey KR; Averna M; Redfield MM; Rodeheffer RJ; Burnett JC
J Am Coll Cardiol; 2011 Aug; 58(6):629-36. PubMed ID: 21798427
[TBL] [Abstract][Full Text] [Related]
17. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.
Lubien E; DeMaria A; Krishnaswamy P; Clopton P; Koon J; Kazanegra R; Gardetto N; Wanner E; Maisel AS
Circulation; 2002 Feb; 105(5):595-601. PubMed ID: 11827925
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide as a biochemical marker of left ventricular diastolic function: assessment in asymptomatic patients 1 year after valve replacement for aortic stenosis.
Mannacio V; Antignano A; De Amicis V; Di Tommaso L; Giordano R; Iannelli G; Vosa C
Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):371-7. PubMed ID: 23656924
[TBL] [Abstract][Full Text] [Related]
19. Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide.
Lanfear DE; Chow S; Padhukasahasram B; Li J; Langholz D; Tang WH; Williams LK; Sabbah HN
J Card Fail; 2014 Sep; 20(9):662-8. PubMed ID: 24983826
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma concentrations of N-terminal pro-brain natriuretic peptide reflect the presence of mildly reduced left ventricular diastolic function in hypertension.
Furumoto T; Fujii S; Mikami T; Inoue M; Nishihara K; Kaga S; Imagawa S; Goto K; Komuro K; Yamada S; Onozuka H; Kitabatake A; Sobel BE
Coron Artery Dis; 2006 Feb; 17(1):45-50. PubMed ID: 16374141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
